Schedule 13D ownership disclosure
Aurinia Pharmaceuticals Inc
Security class unavailable · CUSIP: 05156V102
Event date: 2022-02-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,708,712
- Percent of class
- 4.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-030015
- Form type
- SC 13D
- Filer
- Aurinia Pharmaceuticals Inc.
- CIK
- CIK 1600620
- Filed
- Mar 03, 2022
- Reporting period
- Feb 28, 2022
- Description
- Schedule 13D beneficial ownership